Males with type-2 diabetes are three to four times more likely to die from cardiovascular disease than men without the condition, a new report has revealed.

The study, which is published in the Canadian Medical Association Journal, also showed that men who had suffered from a heart attack or stroke were equally as likely to die from a cardiovascular problem.

According to report author Dr Gilles Dagenais: "Men with type-2 diabetes and no previous cardiovascular disease had a three-fold cardiovascular mortality risk compared with men with neither cardiovascular disease nor diabetes at the beginning of the follow-up."

Men who had been diagnosed with type-2 diabetes within the last five years were at a lower risk of dying from a cardiovascular condition than men who had suffered a heart attack or stroke, although this risk evened out between the groups in the long term.

The findings represent a serious men's health issue and outline the need for effective prevention of diabetes, stroke and heart disease.

Scientists in Finland last month discovered disturbances in lipid and amino acid metabolism in children who later developed type-1 diabetes.

Login and visit the Diabetes Knowledge Centre

• Carbon monoxide could reverse gastroparesis, findings suggest 02/06/09
• Blood sugar levels should be controlled intensively, organisation suggests 26/05/09
• Newly-discovered gene could affect abnormal production of sugar in the liver, researchers say 22/05/09
• Telemedicine could improve diabetes care in children, study suggests 21/05/09
• Diabetes patients with retinopathy should be tested for OSA, researchers say 20/05/09

• PRANDIN Tablets - 86.6%
  ... in patients with type 2 diabetes (Non Insulin-Dependent Diabetes Mellitus (NIDDM)) whose hyperglycaemia can no longer be controlled satisfactorily by diet, weight reduction and exercise. Repaglinide is also indicated in combination with metformin in type 2 diabetes patients who are not ...
  
  
• DDAVP - 86.58%
  ... and treatment of vasopressin-sensitive cranial diabetes insipidus; establishing renal concentration capacity. DDAVP Tablets: Treatment of vasopressin-sensitive cranial diabetes insipidus; treatment of post-hypophysectomy polyuria/ polydipsia. DDAVP/Desmopressin Injection: Cranial diabetes insipidus ...
  
  
• JANUVIA Film-Coated Tablets - 83.51%
  JANUVIA is indicated in patients with type 2 diabetes mellitus to improve glycaemic control in combination with metformin when diet and exercise, plus metformin do not provide adequate glycaemic control. For patients with type 2 diabetes mellitus in whom use of a PPAR? agonist (i.e. a ...
  
  
• EXUBERA - 83.51%
  ... for the treatment of adult patients with type 2 diabetes mellitus not adequately controlled with oral antidiabetic agents and requiring insulin therapy. EXUBERA is also indicated for the treatment of adult patients with type 1 diabetes mellitus, in addition to long or intermediate acting ...
  
  
• HUMALOG - 83.51%
  For the treatment of adults and children with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. HUMALOG, HUMALOG Pen or HUMALOG KwikPen is also indicated for the initial stabilisation of diabetes mellitus ...
  
  
• Chlorpropamide - 83.51%
  Diabetes mellitus. Diabetes insipidus ...